Caricamento...
Clinical Determinants of Successful Omalizumab Therapy in Severe Allergic Asthma Patients: 4-Year-Long, Real-Life Observation
INTRODUCTION: Omalizumab is a high-cost therapy recommended for the treatment of severe allergic asthma. OBJECTIVE: To find clinical parameters that are related to the sustained response to omalizumab. PATIENTS AND METHODS: This retrospective, real-life, 4-year follow-up was provided in Poland betwe...
Salvato in:
| Pubblicato in: | J Asthma Allergy |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754267/ https://ncbi.nlm.nih.gov/pubmed/33363390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S282203 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|